The 7.5 million residents in the northeastern port face curbs on public transport and citizens were warned against leaving for unnecessary reasons

Bank Negara Malaysia reaffirms the government’s growth forecast for this year at 3-4% and for 2022 at 5.5-6.5%.

Third jabs look set to become a central part of the country’s virus management in 2022 but employers are yet to make a call on whether they should be mandatory

CEO Christophe Weber has streamlined operations by selling off consumer pharmaceutical and diabetic treatment businesses

Changes mean travellers who have received China's Sinovac and Sinopharm will be considered as 'fully vaccinated' in Britain

China’s slowdown is likely to intensify, according to analysts at Nomura. They say four negative shocks will hit growth until a threshold is reached in early 2022

Authorities in the Asian financial hub have tightened quarantine and patient discharge rules to convince Beijing to allow cross-border travel

A thick haze of smog blanketed swathes of northern China on Friday, with visibility in some areas reduced to less than 200 metres

Chengdu-based biotech company is still to gain regulatory approval for its jab, which has been pre-ordered by global vaccine alliance GAVI

Company obtained a $360 million grant from the Coalition for Epidemic Preparedness Innovations, the disease research funding group, and its launch customer will be the Global Vaccine Alliance

Current reserves of cereal crops are at historically high levels after several bumper harvests, a food security official said

Sufficiency Economy City allegedly failed to deliver 2 million boxes of nitrile gloves worth $15.5 million for which it had been paid a 40% deposit